Company profile
Teleflex Incorporated
NYSE: TFX · Healthcare · Medical - Instruments & Supplies
#112 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
77B+FH 68DQ 90GM 66SS 96
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ growth stability, balance-sheet leverage
Methodology →Revenue TTM
$2.8B
Rev growth YoY (TTM)
-6.6%
Net income (FY)
-$905.6M
Employees
15,500
as of 2026-08-07
Market cap
$6.1B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.0B$2.0B2025
Net income-$905.6M-$905.6M2025
Operating income$118.4M$118.4M2025
Total assets$6.9B$6.9B2025
Liabilities$3.8B$3.8B2025
Equity$3.1B$3.1B2025
Revenue trend
FY2025 – FY2025 · USD
FY25
FY25
FY25
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Vascular Access46%
Interventional33%
Surgical21%
Other0%
By geography
UNITED STATES63%
EMEA26%
Asia12%
The read
What is Teleflex Incorporated’s revenue?
Teleflex Incorporated booked $2.0B in FY2025 revenue, growing 251% year over year — faster than 90% of Healthcare companies we track, at a -45.4% net margin.
Peers · Healthcare
Concentra Group Holdings Parent, Inc.68BPrivia Health Group, Inc.68BRadNet, Inc.73BModerna, Inc.52DClover Health Investments, Corp.58CPediatrix Medical Group, Inc.76B+Neighbors
Delaware →Key facts
CEOJason Weidman
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersWayne, PA
ExchangeNYSE: TFX
Employees15,500
IPO date1980-03-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.